Gianluca Trifiró is an MD with an MSc in clinical epidemiology, a post-graduation degree in clinical pharmacology and a PhD in pharmacoepidemiology. He is currently working as an assistant professor at both the Erasmus University Medical Center in Rotterdam, The Netherlands and the University of Messina in Italy.
In recent years, his main research activities have focused on the scientific coordination and management of multicentre, national and international multi-database studies (i.e. EU-ADR, ARITMO, SAFEGUARD, MPI-AGE). These assessed post-marketing drug use and safety using multiple European electronic medical record databases.
He is a member of the Sicilian regional committee on biosimilar use, a member of the scientific secretariat of the pharmacovigilance office of the Italian Drug Agency, and an external consultant for the Italian College of General Practitioners focusing on the conduct of pharmacoepidemiology studies using the GP nationwide-database.
Since 2007, he is a referee for research grants funded by the European Commission (FP7 and Horizon 2020 program).
He has authored more than 100 peer-reviewed scientific publications in international journals and is an editor and reviewer for several international journals in the area of pharmacovigilance and pharmacoepidemiology.